Results 61 to 70 of about 74,225 (263)

TNBC cell lines are more mesenchymal, proliferative and migratory as compared to non-TNBC cell lines.

open access: yes, 2018
(A) The morphology of estrogen-receptor (ER)-positive or non-TNBC cell lines (MCF-7, T47-D, MDA-MB-361 and BT-474) and TNBC cell lines (MDA-MB-231, HS-578T, BT-549, MDA-MB-468 and HCC-1806) are shown.
Simone Howard (5733782)   +10 more
core   +1 more source

Blood Cell‐Camouflaged Liquid Metal Nanoconjugates Orchestrate Treg Depletion and STING‐Amplified Photothermal Immunity for Metastatic Triple‐Negative Breast Cancer Therapy

open access: yesAdvanced Science, EarlyView.
Whole‐blood biomimetic engineering transforms liquid metal nanoparticles into a tripartite immunotherapeutic platform that orchestrates regulatory T‐cell depletion, photothermal‐induced immunogenic cell death, and activation of the stimulator of interferon genes pathway.
Nina Sang, Eijiro Miyako
wiley   +1 more source

CPEB2 Affects Malignant Progression of Triple-Negative Breast Cancer Through MEK/ERK Signaling Pathway

open access: yesZhongliu Fangzhi Yanjiu
ObjectiveTo investigate the expression of CPEB2 in triple-negative breast cancer (TNBC) and its impact on the malignant progression of tumors. MethodsThe expression level of CPEB2 in breast cancer was analyzed through a database, and the differential ...
Munire·ABULA, Yuxiang LI, Tao WU
doaj   +1 more source

REaCT TNBC CONSORT participant flowchart.

open access: yes, 2018
REaCT TNBC CONSORT participant flowchart.
John Hilton (2424955)   +6 more
core   +1 more source

The Landscape of Targeted Therapies in TNBC

open access: yes, 2020
Triple negative breast cancer (TNBC) constitutes the most aggressive molecular subtype among breast tumors. Despite progress on the underlying tumor biology, clinical outcomes for TNBC unfortunately remain poor.
Elena Vagia   +2 more
core   +1 more source

Overcoming Drug Resistance by Paclitaxel Resistance in Triple‐Negative Breast Cancer

open access: yesAdvanced Science, EarlyView.
In the murine triple‐negative breast cancer (TNBC) model, chemotherapy effectively increases tumor neoantigen burden (TNB). Here, the study constructs a liposomal nanovaccine using antigens derived from in vitro chemotherapy‐treated paclitaxel‐resistant TNBC 4T1 cells.
Bo Chen   +10 more
wiley   +1 more source

Secondary cancers in breast cancer survivors. A two-centre study

open access: yesArchives of Medical Science
Introduction The risk of secondary cancers in breast cancer survivors remains a significant concern. This study aimed to evaluate the association between treatment modalities and the time to development of secondary cancers in patients after mastectomy ...
Mateusz Wichtowski   +10 more
doaj   +1 more source

Inorganic Nanomaterials can Promote or Inhibit Tumor Metastasis Depending on Tumor Microenvironment Composition

open access: yesAdvanced Science, EarlyView.
As engineered nanomaterials gain prominence in cancer imaging and therapy, understanding their impact on tumor progression becomes increasingly critical. We demonstrate that gold and silica‐coated gold nanomaterials can either suppress or enhance breast cancer metastasis through distinct tumor microenvironment interactions, while identifying ...
Kiana Buttiens   +11 more
wiley   +1 more source

MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients

open access: yesBreast Cancer: Targets and Therapy, 2021
Ibnu Purwanto,1 Didik Setyo Heriyanto,2 Irianiwati Widodo,2 Mohammad Hakimi,3 Mardiah Suci Hardianti,1 Teguh Aryandono,4 Sofia Mubarika Haryana5 1Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Public ...
Purwanto I   +6 more
doaj  

Clinical parameters of TNBC subtypes.

open access: yes, 2016
Clinical parameters of TNBC subtypes.
Harold L. Moses (28594)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy